cbd beta-2 adrenergic receptor
Unlocking 13% Anxiety Relief With Cannabis
A 2023 study found that CBD reduces anxiety by about 13% by activating the body’s beta-2 adrenergic receptors. This mechanism challenges the older view that cannabinoids work only through CB1 and CB2 receptors. The finding opens new therapeutic pathways for anxiety disorders. Legal Disclaimer: This content is for informational